These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 8678189)
1. Dexamethasone for depression. Mitchell AJ Am J Psychiatry; 1996 Aug; 153(8):1111-2; author reply 1112-3. PubMed ID: 8678189 [No Abstract] [Full Text] [Related]
2. Dexamethasone for depression. Wolkowitz OM; Reus VI; Manfredi F; Chan T; Ormiston S; Johnson R Am J Psychiatry; 1996 Aug; 153(8):1112; author reply 1112-3. PubMed ID: 8678190 [No Abstract] [Full Text] [Related]
3. The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness. Bodani M; Sheehan B; Philpot M J Psychopharmacol; 1999; 13(2):196-7. PubMed ID: 10475727 [TBL] [Abstract][Full Text] [Related]
4. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study. Shahal B; Piel E; Mecz L; Kremer I; Klein E Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923 [No Abstract] [Full Text] [Related]
5. Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Preskorn SH; Weller EB; Hughes CW; Weller RA; Bolte K Psychopharmacol Bull; 1987; 23(1):128-33. PubMed ID: 3602308 [No Abstract] [Full Text] [Related]
6. Potentiating effect of estrogen in a patient with treatment-resistant depression. Berlanga C J Clin Psychiatry; 1988 Dec; 49(12):504. PubMed ID: 2848799 [No Abstract] [Full Text] [Related]
7. NIMH report. Five-center study clarifies use of lithium, imipramine for recurrent affective disorders. Prien RF Hosp Community Psychiatry; 1984 Nov; 35(11):1097-8. PubMed ID: 6389308 [No Abstract] [Full Text] [Related]
9. Efficacy of imipramine in psychotic versus nonpsychotic depression. Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726 [TBL] [Abstract][Full Text] [Related]
10. Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression". Baldessarini RJ J Clin Psychopharmacol; 2008 Dec; 28(6):716; author reply 717-8. PubMed ID: 19011451 [No Abstract] [Full Text] [Related]
11. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression. Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126 [TBL] [Abstract][Full Text] [Related]
12. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. Thase ME; Kupfer DJ; Jarrett DB J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995 [TBL] [Abstract][Full Text] [Related]
13. Dexamethasone suppression test and mood response to methylphenidate in primary depression. Brown P; Brawley P Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911 [TBL] [Abstract][Full Text] [Related]
14. A trial of adjunctive imipramine in postpsychotic depression. Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903 [No Abstract] [Full Text] [Related]
15. Combined treatment with imipramine and mianserin. A controlled pilot study. Lauritzen L; Clemmesen L; Klysner R; Loldrup D; Lunde M; Schaumburg E; Waarst S; Bech P Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957 [TBL] [Abstract][Full Text] [Related]
16. Research overview of drug therapy in recurrent and chronic depression. Prien RF Adv Biochem Psychopharmacol; 1985; 40():121-30. PubMed ID: 3895838 [No Abstract] [Full Text] [Related]
17. The dexamethasone suppression test in panic disorder and agoraphobia. Curtis GC; Cameron OG; Nesse RM Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428 [TBL] [Abstract][Full Text] [Related]